The Scripps Translational Science Institute is conducting a study to determine if the use of a novel Wearable Intensive Nerve Stimulation (WINS) device, called Quell and its<br>associated mobile application can help treat cancer related pain. Better treatment of pain could mean not having to take as many pain medications. Requires 6 study visits at Scripps Mercy Cancer Center
Be male or female 18 years or older at visit one.
Have a documented diagnosis of metastatic breast, prostate, stage 3 or 4 head and neck cancers, or colorectal cancer with a prognosis of 6 month or greater as determined by the primary oncologist.
Own a smart phone and able to use basic mobile applications such as downloading an app, opening the app, and performing one simple task within the app.
Speak and read English fluently.
Be able to understand and grant informed consent.
Live in an area with cellular data connectivity available
Comply with clinic follow up visits
Be using at least one opioid medication on a daily basis.
Have a cardiac pacemaker, implanted defibrillator or other implanted electronic device.
Be unable to complete subjective data as required; e.g. on mobile application and questionnaires.
Live outside of an area with suitable cellular data connectivity.